Adams Diversified Equity Fund Inc. Acquires New Shares in CME Group Inc. (NASDAQ:CME)

Adams Diversified Equity Fund Inc. acquired a new stake in CME Group Inc. (NASDAQ:CME - Free Report) during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 87,100 shares of the financial services provider's stock, valued at approximately $23,107,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in CME. New Age Alpha Advisors LLC lifted its position in CME Group by 50.0% in the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after acquiring an additional 43 shares in the last quarter. Knuff & Co LLC bought a new position in CME Group in the 4th quarter valued at approximately $33,000. Banque Transatlantique SA purchased a new stake in CME Group during the 4th quarter valued at $35,000. Whipplewood Advisors LLC purchased a new stake in CME Group during the 4th quarter valued at $37,000. Finally, United Community Bank purchased a new stake in CME Group during the 4th quarter valued at $37,000. 87.75% of the stock is owned by institutional investors.

CME Group Trading Down 0.5%

Shares of CME Group stock opened at $271.38 on Wednesday. The company has a market capitalization of $97.79 billion, a P/E ratio of 27.30, a P/E/G ratio of 3.70 and a beta of 0.45. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The company has a fifty day moving average of $274.52 and a 200 day moving average of $255.92. CME Group Inc. has a fifty-two week low of $192.11 and a fifty-two week high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.61 by $0.19. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The business had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the prior year, the firm earned $2.50 EPS. The business's revenue was up 10.4% on a year-over-year basis. On average, sell-side analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.84%. The ex-dividend date is Monday, June 9th. CME Group's dividend payout ratio (DPR) is presently 50.30%.

Insider Buying and Selling at CME Group

In related news, Director Larry G. Gerdes sold 2,000 shares of the stock in a transaction dated Thursday, April 24th. The shares were sold at an average price of $264.10, for a total value of $528,200.00. Following the completion of the transaction, the director now owns 38,651 shares of the company's stock, valued at approximately $10,207,729.10. This trade represents a 4.92% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Derek Sammann sold 4,650 shares of the stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the completion of the transaction, the insider now directly owns 8,336 shares of the company's stock, valued at approximately $2,339,164.96. The trade was a 35.81% decrease in their position. The disclosure for this sale can be found here. Insiders sold 13,400 shares of company stock valued at $3,680,610 in the last 90 days. Insiders own 0.30% of the company's stock.

Analyst Ratings Changes

CME has been the subject of a number of research reports. Piper Sandler boosted their target price on shares of CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a research note on Tuesday, April 8th. Oppenheimer boosted their target price on shares of CME Group from $282.00 to $300.00 and gave the company an "outperform" rating in a research note on Wednesday, June 4th. Bank of America boosted their target price on shares of CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a research note on Wednesday, April 2nd. Erste Group Bank lowered shares of CME Group from a "strong-buy" rating to a "hold" rating in a research note on Saturday, May 24th. Finally, JPMorgan Chase & Co. decreased their target price on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research note on Thursday, April 24th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average target price of $258.20.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.